Date,Title,Source
2025-09-06T06:16:56Z,Biotech Stocks To Consider – September 4th,ETF Daily News
2025-09-05T09:41:12Z,Biotech Stocks To Consider – September 2nd,ETF Daily News
2025-09-05T05:42:51Z,Top Biotech Stocks Worth Watching – September 3rd,ETF Daily News
2025-09-04T08:32:58Z,Promising Biotech Stocks To Add to Your Watchlist – September 1st,ETF Daily News
2025-09-03T21:00:05Z,Here's How Much You Would Have Made Owning AbbVie Stock In The Last 5 Years,Biztoc.com
2025-09-03T17:41:21Z,AbbVie (ABBV) Advances Cancer Treatments With Epcoritamab And Mirvetuximab Approvals,Yahoo Entertainment
2025-09-03T07:02:52Z,Biotech Stocks To Research – August 31st,ETF Daily News
2025-09-02T07:27:47Z,"AbbVie Inc. (ABBV) Acquires Psychedelic Drug Developer Gilgamesh for $1.2B, Enters Mental Health Market",Yahoo Entertainment
"Sat, 06 Sep 2025 17:17:05 GMT",AbbVie (ABBV) Declares US$1.64 Quarterly Dividend for Shareholders - Yahoo Finance,Yahoo Finance
"Fri, 05 Sep 2025 13:07:00 GMT",AbbVie Declares Quarterly Dividend - PR Newswire,PR Newswire
"Wed, 03 Sep 2025 17:48:45 GMT",AbbVie (ABBV) Advances Cancer Treatments With Epcoritamab And Mirvetuximab Approvals - simplywall.st,simplywall.st
"Fri, 05 Sep 2025 13:09:32 GMT",AbbVie (ABBV) Declares $1.64 Quarterly Dividend; 3.1% Yield - StreetInsider,StreetInsider
"Thu, 04 Sep 2025 19:40:26 GMT",AbbVie Inc. (NYSE:ABBV) Is a Favorite Amongst Institutional Investors Who Own 74% - 富途牛牛,富途牛牛
"Thu, 04 Sep 2025 17:48:45 GMT",AbbVie’s ABBV-400 Study: A New Hope for Advanced Solid Tumors - TipRanks,TipRanks
"Wed, 03 Sep 2025 06:55:09 GMT",Volume spikes in ABBV stock – what they mean - Weekly Profit Analysis & Long-Term Safe Investment Plans - Newser,Newser
"Sat, 06 Sep 2025 09:25:39 GMT",ABBV Shows Risk Reward Favoring Upside - Market Trend Review & Weekly Consistent Profit Watchlists - beatles.ru,beatles.ru
"Wed, 03 Sep 2025 12:30:00 GMT",92% Outpatient Success: AbbVie's Breakthrough Lymphoma Drug Shows Promise in Earlier Treatment Line - Stock Titan,Stock Titan
"Fri, 05 Sep 2025 18:26:02 GMT",Is ABBV backed by strong institutional buying - July 2025 Big Picture & Safe Capital Allocation Plans - خودرو بانک,خودرو بانک
"Tue, 02 Sep 2025 07:54:04 GMT","AbbVie Inc. (ABBV) Acquires Psychedelic Drug Developer Gilgamesh for $1.2B, Enters Mental Health Market - MSN",MSN
"Wed, 03 Sep 2025 06:54:46 GMT",How hedge fund analytics apply to ABBV stock - Quarterly Portfolio Report & Target Return Focused Picks - Newser,Newser
"Tue, 02 Sep 2025 10:45:15 GMT",Assessing AbbVie (ABBV) Valuation Following New Clinical Trial Breakthroughs and Upward Earnings Revisions - simplywall.st,simplywall.st
"Sat, 06 Sep 2025 09:02:38 GMT",What is ABBV’s book value per share - July 2025 Trade Ideas & Step-by-Step Swing Trade Plans - خودرو بانک,خودرو بانک
"Thu, 04 Sep 2025 12:10:20 GMT",What institutional flow reveals about ABBV - CPI Data & Community Consensus Stock Picks - Newser,Newser
"Fri, 05 Sep 2025 01:54:51 GMT",What is ABBV’s book value per share - Weekly Trade Summary & Stock Timing and Entry Methods - خودرو بانک,خودرو بانک
"Wed, 03 Sep 2025 15:49:11 GMT",Insider Trends: Will ABBV face regulatory challenges - 2025 Performance Recap & Low Risk Growth Stock Ideas - خودرو بانک,خودرو بانک
"Wed, 03 Sep 2025 07:00:00 GMT",Does ABBV have a sustainable dividend - 2025 Performance Recap & Community Trade Idea Sharing Platform - خودرو بانک,خودرو بانک
"Wed, 03 Sep 2025 03:27:11 GMT",Can ABBV expand its profit margins - Trade Exit Summary & Entry Point Strategy Guides - خودرو بانک,خودرو بانک
"Tue, 02 Sep 2025 09:48:56 GMT",Will ABBV outperform tech stocks - July 2025 Update & Free Safe Entry Trade Signal Reports - خودرو بانک,خودرو بانک
"Tue, 02 Sep 2025 21:16:50 GMT",Can ABBV generate free cash flow - M&A Rumor & Daily Profit Maximizing Tips - خودرو بانک,خودرو بانک
"Thu, 04 Sep 2025 13:17:00 GMT",Will AbbVie's Neuroscience Portfolio Continue to Aid Top-line Growth? - TradingView,TradingView
"Wed, 03 Sep 2025 14:22:14 GMT",AbbVie updates mid-stage trial data for Genmab-partnered lymphoma drug in outpatient setting - Seeking Alpha,Seeking Alpha
"Wed, 03 Sep 2025 00:31:25 GMT",AbbVie’s Strategic Acquisitions and Trial Success Fuel 0.72% Rally Despite 102nd-Ranked 920M Volume - AInvest,AInvest
"Sun, 07 Sep 2025 04:56:17 GMT",Is ABBV stock reversal real or fake - Sell Signal & Free Safe Capital Growth Stock Tips - Newser,Newser
"Sun, 07 Sep 2025 03:01:04 GMT",How to integrate ABBV into portfolio analysis tools - 2025 Winners & Losers & Capital Efficiency Focused Ideas - Newser,Newser
"Sun, 07 Sep 2025 05:53:49 GMT",Real time alert setup for ABBV performance - Quarterly Profit Report & Reliable Trade Execution Plans - Newser,Newser
"Sun, 07 Sep 2025 04:40:27 GMT",What institutional flow reveals about ABBV - Market Movement Recap & Fast Entry and Exit Trade Plans - Newser,Newser
"Sun, 07 Sep 2025 01:38:02 GMT",Sentiment analysis tools applied to ABBV - Weekly Market Summary & Free Safe Entry Trade Signal Reports - Newser,Newser
"Sat, 06 Sep 2025 20:38:52 GMT",What MACD signals say about ABBV - Market Volume Report & Detailed Earnings Play Strategies - Newser,Newser
"Sun, 07 Sep 2025 02:24:57 GMT",Using economic indicators to assess ABBV potential - Rate Hike & Reliable Price Breakout Signals - Newser,Newser
"Sun, 07 Sep 2025 05:02:06 GMT",Assessing AbbVie’s Dividend Sustainability Amid Evolving Market Dynamics - AInvest,AInvest
"Sun, 07 Sep 2025 00:41:56 GMT",AbbVie's Dividend Resilience and Growth Prospects in a Shifting Market - AInvest,AInvest
"Sat, 06 Sep 2025 23:50:02 GMT",Why AbbVie's Dividend Resilience Signals Strong Long-Term Investment Potential - AInvest,AInvest
"Sun, 07 Sep 2025 03:34:40 GMT",How to interpret RSI for ABBV stock - 2025 Stock Rankings & Precise Swing Trade Entry Alerts - Newser,Newser
"Sun, 07 Sep 2025 03:57:57 GMT",How to integrate ABBV into portfolio analysis tools - Quarterly Trade Review & Free Daily Entry Point Trade Alerts - Newser,Newser
"Sun, 07 Sep 2025 02:39:21 GMT",How to interpret RSI for ABBV stock - CPI Data & Expert Approved Momentum Ideas - Newser,Newser
"Sat, 06 Sep 2025 21:54:58 GMT",Applying Elliott Wave Theory to ABBV - Breakout Watch & Real-Time Volume Analysis Alerts - Newser,Newser
"Sat, 06 Sep 2025 07:27:20 GMT",AbbVie Inc. ABBV Posts 0.21% Drop Amid Short-Term Challenges and Strategic Shifts - AInvest,AInvest
"Sat, 06 Sep 2025 17:53:51 GMT",AbbVie’s Dividend Sustainability and Valuation: Does the High Yield Justify the Price? - AInvest,AInvest
"Sun, 07 Sep 2025 00:13:19 GMT",Using Bollinger Bands to evaluate ABBV - July 2025 Macro Moves & Low Risk High Win Rate Stock Picks - Newser,Newser
"Sat, 06 Sep 2025 07:28:00 GMT",Stock Analysis | Abbvie Outlook - Technical Strength and Optimism Amid Strong Analyst Backing - AInvest,AInvest
"Tue, 02 Sep 2025 07:33:01 GMT","AbbVie Inc. (ABBV) Acquires Psychedelic Drug Developer Gilgamesh for $1.2B, Enters Mental Health Market - Insider Monkey",Insider Monkey
"Fri, 05 Sep 2025 00:54:06 GMT","AbbVie Shares Rise 0.54% on Epcoritamab Trial Progress, Daily Volume Ranks 119th - AInvest",AInvest
"Sun, 07 Sep 2025 04:12:03 GMT",Assessing AbbVie's Dividend Sustainability Amidst Earnings Volatility - AInvest,AInvest
"Fri, 05 Sep 2025 15:04:02 GMT",AbbVie Inc. Announces Quarterly Dividend of $1.64 per Share - AInvest,AInvest
"Sat, 06 Sep 2025 01:07:04 GMT",AbbVie's $950M Volume Drives 90th Market Rank Amid 310% Dividend Surge and Therapeutic Expansion - AInvest,AInvest
"Thu, 04 Sep 2025 00:58:21 GMT",AbbVie’s $0.84 Billion Volume Tumbles to 100th as Regulatory Uncertainty and Biosimilar Delays Weigh on Investor Sentiment - AInvest,AInvest
"Fri, 05 Sep 2025 07:26:32 GMT",Stock Analysis | Abbvie Outlook - Technical Neutrality and Strong Fundamentals Amid Mixed Analyst Ratings - AInvest,AInvest
"Tue, 02 Sep 2025 07:05:37 GMT",Stock Analysis | Abbvie Outlook - Technical Neutrality and Mixed Analyst Signals - AInvest,AInvest
2025-09-05T16:07:00,AbbVie Declares Quarterly Dividend,Yahoo
2025-09-04T16:17:00,Will AbbVie's Neuroscience Portfolio Continue to Aid Top-line Growth?,Yahoo
2025-09-04T13:41:02,AbbVie and Genmab’s Epkinly shows outpatient viability in Phase II trial,Yahoo
2025-09-04T12:46:00,Anti-Parkinson's Drugs Global Market Research Report 2025-2030 | $9.2 Bn Opportunities Driven by Increased Awareness in Emerging Countries and a Robust Pipeline of Innovations,Yahoo
2025-09-04T12:05:13,Health Canada approves AbbVie’s Elahere for ovarian cancer,Yahoo
2025-09-03T20:41:21,AbbVie (ABBV) Advances Cancer Treatments With Epcoritamab And Mirvetuximab Approvals,Yahoo
2025-09-03T15:30:00,AbbVie Announces Updated Results From Phase 2 EPCORE® NHL-6 Study Evaluating the Potential for Outpatient Monitoring of Epcoritamab in Patients With Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL),Yahoo
2025-09-03T15:00:00,Allergan Aesthetics Launches Campaign to Educate Consumers about Hyaluronic Acid (HA) Injectable Fillers,Yahoo
2025-09-02T19:44:00,Health Canada Approves ELAHERE® for Certain Types of Platinum-Resistant Ovarian Cancers,Yahoo
2025-09-02T15:02:00,AbbVie Gets Health Canada Approval for Ovarian-Cancer Treatment,MarketWatch
2025-09-02T15:00:00,AbbVie to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference,Yahoo
2025-09-02T10:27:47,"AbbVie Inc. (ABBV) Acquires Psychedelic Drug Developer Gilgamesh for $1.2B, Enters Mental Health Market",Yahoo
